[EN] NEW CRBN MODULATORS<br/>[FR] NOUVEAUX MODULATEURS DU CRBN
申请人:DANA FARBER CANCER INST INC
公开号:WO2020006262A1
公开(公告)日:2020-01-02
Disclosed are degraders, pharmaceutical compositions containing them, and methods of making and using the degraders to treat diseases and disorders characterized by dysregulated or dysfunctional protein activity that can be targeted by cereblon.